Time-dependent recovery of in vivo binding sites after drug dosing: a method for radiotracer evaluation.
The recovery of in vivo binding sites for (+/-)-alpha-[11C] methoxytetrabenazine, a radioligand for the monoamine vesicular transporter (VMAT2), was determined in mouse brain at various times following a pharmacological dose of tetrabenazine. Concentrations of in vivo radioligand binding sites progressively increased and had reached control values by 8.5 h, and this recovery was consistent with the pharmacokinetics of the competing drug tetrabenazine and its active metabolite, dihydrotetrabenazine. This study demonstrates a simple experimental protocol of using a single dose of a reversible competing drug and time-dependent measurements of in vivo binding of a radioligand. This protocol is suitable for testing the sensitivity of an in vivo radiotracer for measurement of varying concentrations of in vivo binding sites.
Kilbourn
M R
MR
Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor 48109, USA.
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D005260:Female; D007275:Injections, Intravenous; D051379:Mice; D011869:Radioligand Assay; D013747:Tetrabenazine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D013997:Time Factors
D018759:Adrenergic Uptake Inhibitors; C084867:5-O-methyldihydrotetrabenazine; C032811:dihydrotetrabenazine; D013747:Tetrabenazine